Back
Expedia Group Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
64
EXPE
Expedia Group
Last Price:
132.25
Seasonality Move:
4.87%
Sell
19
ITCI
Intra-Cellular Therapies
Last Price:
73.53
Seasonality Move:
7.83%
Buy
64
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $132.28. The Score for EXPE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- EXPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $73.52. The Score for ITCI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $132.28
The current trend is moderately bearish and EXPE is experiencing selling pressure, which indicates risk of future bearish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $73.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
EXPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.36 | Buy |
Relative Strength Index (14 RSI): | 49.18 | Sell |
Chaikin Money Flow: | -752249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (122.14 - 139.16) | Buy |
Bollinger Bands (100): | (116.58 - 134.54) | Buy |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.75 | Sell |
Relative Strength Index (14 RSI): | 46.1 | Sell |
Chaikin Money Flow: | -514822 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.04 - 76.28) | Sell |
Bollinger Bands (100): | (68.13 - 76.69) | Buy |
EXPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 137.45 | Sell |
20-day SMA: | 134.5 | Sell |
50-day SMA: | 129.67 | Buy |
200-day SMA: | 133.53 | Sell |
8-day EMA: | 135.61 | Sell |
20-day EMA: | 133.92 | Sell |
50-day EMA: | 130.39 | Buy |
200-day EMA: | 127.15 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.98 | Buy |
20-day SMA: | 74.25 | Sell |
50-day SMA: | 75.03 | Sell |
200-day SMA: | 69.81 | Buy |
8-day EMA: | 73.25 | Buy |
20-day EMA: | 74.11 | Sell |
50-day EMA: | 74.13 | Sell |
200-day EMA: | 69.38 | Buy |
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.13 per share, an increase next quarter of $1.06 per share, an increase this year of $2.07 per share, and an increase next year of $2.51 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
Expedia Group Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |